These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 22305987

  • 1. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C, Chen CY, Evans D, Maskew M, Schulz D, Reyneke A, Kramvis A.
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [Abstract] [Full Text] [Related]

  • 2. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 3. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Nov 01; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 5. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ.
    J Med Virol; 2009 Mar 01; 81(3):406-12. PubMed ID: 19152393
    [Abstract] [Full Text] [Related]

  • 6. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 01; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep 01; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 8. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct 01; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 9. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan 01; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 10. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 01; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 11. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 01; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 12. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S.
    Mikrobiyol Bul; 2011 Apr 01; 45(2):353-8. PubMed ID: 21644079
    [Abstract] [Full Text] [Related]

  • 13. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan 01; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.
    J Med Virol; 2012 Jan 01; 84(1):6-10. PubMed ID: 22095533
    [Abstract] [Full Text] [Related]

  • 15. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep 01; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.
    Aires RS, Matos MA, Lopes CL, Teles SA, Kozlowski AG, Silva AM, Filho JA, Lago BV, Mello FC, Martins RM.
    J Clin Virol; 2012 Aug 01; 54(4):327-31. PubMed ID: 22608842
    [Abstract] [Full Text] [Related]

  • 17. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
    Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.
    J Med Virol; 2012 Jun 01; 84(6):857-65. PubMed ID: 22499006
    [Abstract] [Full Text] [Related]

  • 18. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, ANRS 1236 DITRAME-B&C Study Group.
    J Med Virol; 2004 Sep 01; 74(1):34-40. PubMed ID: 15258966
    [Abstract] [Full Text] [Related]

  • 19. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C, Berger A, Carlebach A, Lutz T, Bickel M, Klauke S, Staszewski S, Stuermer M.
    J Antimicrob Chemother; 2005 Dec 01; 56(6):1087-93. PubMed ID: 16269552
    [Abstract] [Full Text] [Related]

  • 20. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
    Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G.
    AIDS; 2007 Oct 18; 21(16):2171-5. PubMed ID: 18090043
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.